Canopy Growth shares rose after the company agreed to acquire MTL Cannabis in a deal valued at $179 million on an enterprise basis. The transaction is expected to be accretive, deliver about $10 million in annual synergies within 18 months, and strengthen CGC's flower supply for European medical markets.